Scanning insider filings daily

Track the
Smart Money

Algorithmic insider trading analysis from public regulatory filings. Multi-factor scoring, transparent track record, and daily analysis.

Start Free 7-Day Trial See How It Works

7 days free, then $3.99/mo. Cancel anytime.

0
Filings Scanned
0
Analyses
0
Positions Tracked
0
Signals This Month

Everything you need
to follow insider money

Insider Filing Scanner
We scan insider transaction filings daily for CEO open-market purchases. Not option exercises, not grants — real money voluntarily deployed.
$ app:scan-edgar
FOUND CEO open-market purchase detected
TICKER ACME · VALUE $2,450,000
$ app:run-analysis ✓
Multi-Factor Analysis
Every purchase scored across fundamental, financial, and technical dimensions. Weighted composite score from 0-100 using real-time market data.
Fundamental
82
Financial
74
Technical
88
Mock Portfolio
Every analysis is tracked in a hypothetical portfolio with full transparency. Performance benchmarked against the market so you can verify results yourself.
+4.35%
Avg Return
+2.22%
Alpha vs S&P
200
Positions
Hypothetical positions, not real trades. Past performance does not guarantee future results.
Daily Newsletter
Today's insights, portfolio updates, and performance metrics delivered to your inbox every morning.

Recent analyses

Real signals from our pipeline — analyses shown after 7-day delay.

SMMT Health Care (Biotechnology)
Summit Therapeutics Inc.
BUY
60.0
Insider: Zanganeh Mahkam Purchase: $49,987,200 Jun 12, 2026
Fundamental 65/100
Summit Therapeutics is a clinical-stage oncology biopharmaceutical company primarily focused on its lead asset, ivonesci...
Financial 35/100
The company is currently unprofitable with substantial cash burn and no product revenue, although it maintains a debt-fr...
Technical 60/100
SMMT stock has recently rebounded after a decline and is currently consolidating within a defined trading range, holding...
Insider Context: Co-CEO Zanganeh Mahkam, with a history of profitable insider purchases, made a massive $49.98M buy on a recent dip near the 52-week low. This, along with a coinciding purchase by Co-CEO Robert W. Duggan, signals very strong conviction from leadership despite recent market challenges and the withdrawn public offering.
MSA Industrials
MSA Safety Inc
BUY
60.7
Insider: BECK JULIE A Purchase: $71,093 Jun 12, 2026
Fundamental 85/100
MSA Safety demonstrates a strong business model as a global leader in mission-critical safety solutions, focusing on hig...
Financial 75/100
The company exhibits solid financial performance with consistent mid-single-digit revenue growth and strong profitabilit...
Technical 30/100
MSA's stock is currently in a downtrend, trading below key moving averages, and several momentum indicators (MACD, Momen...
Insider Context: CFO Julie A. Beck made an open-market purchase of 448 shares worth $71,093.07 on June 11, 2026. This marks her first recorded open-market purchase in the last 12 months. The transaction occurred after a strong Q1 2026 earnings beat, but approximately 7-8 weeks before the estimated Q2 2026 earnings, and notably, when the stock was trading closer to its 52-week low following a recent decline. This suggests a conviction buy by the CFO during a price dip.
MZTI Consumer Defensive
MARZETTI CO
BUY
60.2
Insider: Pigott, Thomas K. Purchase: $98,109 Jun 12, 2026
Fundamental 65/100
Marzetti operates in retail and foodservice with established brands, but faces headwinds from slowing organic growth and...
Financial 80/100
The company demonstrates robust financial health with strong profitability margins, minimal debt (0% debt-to-equity), an...
Technical 45/100
MZTI is currently in a downtrend and trading below key moving averages, indicating bearish momentum. However, the stock ...
Insider Context: Thomas K. Pigott, VP, CFO, and Asst. Secretary, made his first open-market purchase of 900 shares worth $98,109 in 12 months. This acquisition occurred after a disappointing Q3 earnings report and amidst a stock price downturn where the stock is considered oversold, suggesting his conviction in the company's long-term prospects at a depressed valuation.

Track Record

Total Signals
200
Avg Return
+4.35%
Alpha vs S&P
+2.22%
Win Rate
79.3%

Since Dec 23, 2025: 200 signals, 84 active · View full track record →

From the blog

Insider buying analysis, SEC filing guides, and market signals.

Education
What Does It Mean When a CEO Buys Their Own Stock?
When a CEO spends personal money buying shares on the open market, it's the strongest conviction signal in finance. But not all insider purchases are equal. Here's how to tell signal from noise.
Mar 31, 2026 · 8 min
Education
Insider Buying vs Selling: Why Only One Predicts Stock Returns
Insiders sell 5x more often than they buy. Does that mean they're bearish? No. Academic research shows insider buying predicts returns, but selling has zero predictive value. Here's why.
Mar 31, 2026 · 9 min
Analysis
Best Stocks to Buy Based on Insider Buying — March 2026
How to identify the most promising stocks from CEO insider purchases. Our 6-factor scoring methodology, what makes an insider buy meaningful, and why 89% of our backtested signals hit their +10% target.
Mar 26, 2026 · 8 min
All posts

How it works
From filing to your inbox

1

Scan

Insider transaction filings scanned daily for CEO open-market purchases

2

Analyze

Multi-factor scoring: fundamental, financial, and technical

3

Track

Every analysis tracked in a live portfolio, benchmarked against the market

4

Deliver

Morning newsletter with insights, portfolio updates, and metrics

See what you'll get

Enter your email and we'll send you a real sample newsletter — free, no commitment.

No spam. Just one sample + one follow-up. That's it.

Simple pricing, clear value.

One plan. Everything included.

Pro
$3.99
per month
  • Daily newsletter
  • Full analysis breakdown
  • 90-day analysis history
  • Portfolio tracking & trade history
  • STRONG BUY instant alerts
  • Source filing links
Start Free 7-Day Trial

7 days free. Cancel anytime.

Frequently asked questions

Yes. Corporate insiders are legally required to publicly report their trades within two business days. We monitor these public filings and analyze them — the same data available to any investor.

No. CEO Trader provides opinions and analysis for educational and informational purposes only. Our portfolio tracks hypothetical positions — no real money is traded. Algorithm-generated analysis may contain errors. Always do your own research and consult a financial advisor.

Tools like Finviz, OpenInsider, and WhaleWisdom show raw data dumps for ALL insiders — every VP, director, and officer across thousands of filings. No filtering, no scoring, no portfolio tracking. CEO Trader focuses exclusively on CEO open-market purchases (the strongest insider signal), then runs each through multi-factor analysis with fundamental, financial, and technical scoring. Every BUY/STRONG BUY gets tracked in a live portfolio benchmarked against the S&P 500.

STRONG BUY > BUY > WATCH > AVOID > STRONG AVOID. Only BUY and STRONG BUY opinions enter the tracked portfolio. Each analysis includes a weighted composite score from 0-100 across fundamental, financial, and technical dimensions.

Yes. Cancel through your account page at any time. Your subscription stays active through the end of the billing period. No questions asked, no hoops to jump through — managed securely through Stripe.

All stocks listed on major US exchanges (NYSE, NASDAQ). We filter out OTC and penny stocks to keep analysis quality high.

Every BUY or STRONG BUY signal enters a mock portfolio with a $100 position alongside a $100 S&P 500 (SPY) benchmark bought the same day. Positions close at +10% (target hit) or -15% (stop loss). Alpha is the difference between our signal return and SPY's return over the same period. Every position — open and closed — is visible on our /track-record page.

Ready to follow the
smart money?

Join CEO Trader for insider buying analysis delivered daily.

Start Free 7-Day Trial

7 days free · then $3.99/mo · Cancel anytime